期刊文献+

重视造血干细胞移植受者生活质量的改善

原文传递
导出
摘要 异基因造血干细胞移植(allo—HSCT)是治疗多种血液系统疾病、遗传性疾病和其他系统恶性或难治性疾病的有效手段。目前allo—HSCT治疗白血病的5年无病存活率已接近60%,治疗遗传性疾病等则更高。近年来,随着移植相关技术的普及、适应证的扩大,全球新增移植例数逐年提高。据国际骨髓移植登记处(IBMTR)统计,1997-2009年全球仅异基因移植的例数已接近30万。日益增加的移植受者构成了一个庞大的特殊社会群体,如何控制疾病进展,防治各类并发症,提高该群体的生活质量,使之真正回归社会,是造血干细胞移植领域的一个极为关键的问题。
作者 邹萍
出处 《中华器官移植杂志》 CAS CSCD 北大核心 2013年第2期69-70,共2页 Chinese Journal of Organ Transplantation
  • 相关文献

参考文献9

  • 1Yan CH,Liu DH,Liu KY. Risk stratification-directed donor lymphocyte infusion could reduce relapse of standardrisk acute leukemia patients after allogeneic hematopoietic stem cell transplantation[J].Blood,2012,(14):3256-3262.
  • 2Qin Y,Zhu H,Jiang B. Expression patterns of WT1 and PRAME in acute myeloid leukemia patients and their usefulness for monitoring minimal residual disease[J].Leukemia Research,2009,(03):384-390.doi:10.1016/j.leukres.2008.08.026.
  • 3Cornelissen JJ,Gratwohl A,Schlenk RF. The European Leukemia Net AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission:an integrated-risk adapted approach[J].Nat Rev Clin Oncol,2012,(10):579-590.
  • 4Colita A,Moise L. Post-transplant lymphoproliferative disorders after solid organ transplantation in children[J].Chirurgia(Bucur),2012,(04):431-437.
  • 5Murukesan V,Mukherjee S. Managing post-transplant lymphoproliferative disorders in solid-organ transplant recipients:a review of immunosuppressant regimens[J].Drugs,2012,(12):1631-1643.
  • 6Bajwa R,Skeens M,Garee A. Metabolic syndrome and endocrine dysfunctions after HSCT in children[J].Pediatric Transplantation,2012,(08):872-878.
  • 7Kikuchi A,Yabe H,Kato K. Long-term outcome of childhood aplastic anemia patients who underwent allogeneic hematopoietic SCT from an HLA-matched sibling donor in Japan[J].Bone Marrow Transplantation,2012.
  • 8Schulz-Kindermann F,Mehnert A,Scherwath A. Cognitive function in the acute course of allogeneic hematopoietic stem cell transplantation for hematological malignancies[J].Bone Marrow Transplantation,2007,(12):789-799.doi:10.1038/sj.bmt.1705663.
  • 9Syrjala KL,Artherholt SB,Kurland BF. Prospective neurocognitive function over 5 years after allogeneic hematopoietic cell transplantation for cancer survivors compared with matched controls at 5 years[J].Journal of Clinical Oncology,2011,(17):2397-2404.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部